期刊文献+

汉族非典型溶血尿毒综合征儿童CFI基因突变分析

Mutations in the CFI gene in children with atypical hemolytic uremic syndrome in Chinese Han ethnic group
下载PDF
导出
摘要 目的分析汉族非典型溶血尿毒综合征(aHUS)儿童CFI基因突变及其特点。方法研究对象为9例汉族aHUS儿童和50例尿检正常的汉族成年人。分别取其外周血3ml,提取基因组DNA,应用聚合酶链式反应(PCR)扩增CFI基因的全部13个外显子及其周围部分内含子。应用正反向引物对PCR产物进行直接DNA序列测定。结果在9例汉族aHUS儿童中未发现CFI基因致病突变;但检测出6个CFI基因多态性,即IVS5+61G>A、804G>A、IVS7+99delT、IVS8-49C>G、IVS11+33A>G和*112C>T。结论CFI基因突变不是本研究9例汉族aHUS儿童的主要致病原因。 Objective To examine mutations in the CFI gene in children with atypical hemolytic uremic syndrome (aHUS) in Chinese Han ethnic group.Methods The mutational analysis of the CFI gene was performed in nine children with aHUS in Chinese Han ethnic group,using polymerase chain reaction and DNA sequencing.Results No causative mutations in the CFI gene were found.However,six CFI polymorphisms were identified,IVS5 + 61G〉 A,804G 〉A,IVS7 + 99delT,IVS8-49C〉 G,IVS11 + 33A〉 G and ^*112C 〉T,in some patients and controls.Conclusions Mutations in the CFI gene is not major cause of aHUS in the nine children of Chinese Han ethnic group in this study.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2010年第4期354-357,共4页 Journal of Clinical Pediatrics
基金 福建省自然科学基金(No.2006J0119) 南京军区医学科学技术研究"十一五"计划课题(No.06MA148和No.06MA151) 2008年度南京军区医学科技创新课题(No.08MA102)
关键词 非典型溶血尿毒综合征 CFI基因 基因突变 汉族 atypical hemolytic uremic syndrome CFI gene mutation Han ethnic
  • 相关文献

参考文献14

  • 1Caprioli J, Noris M, Brioschi S, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome [J]. Blood, 2006,108(4) : 1267-1279.
  • 2Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, et ol. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome [J]. J Am Soc Nephrol,2007,18 (8):2392- 2400.
  • 3Kavanagh D, Kemp EJ, Mayland E, et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome [J]. J Am Soc Nephrol,2005, 16(7) :2150-2155.
  • 4Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome [J]. J Med Genet,2004,41 (6) :e84.
  • 5den Dunnen JT, Antonarakis SE. Nomenclature for the description of human sequence variations [J]. Hum Genet ,2001,109( 1 ) : 121-124.
  • 6唐向国,叶礼燕,余自华,任榕娜,陈光明,王承峰,夏桂枝,黄隽,黄俊景,聂晓晶.溶血尿毒综合征患儿MCP基因突变分析[J].临床儿科杂志,2008,26(12):1045-1048. 被引量:2
  • 7Vyse TJ, Morley BJ, Bartok I, et al. The molecular basis of hereditary complement factor I deficiency [J]. J Clin Invest, 1996,97 (4) : 925-933.
  • 8Catterall CF, Lyons A, Sim RB, et ol. Characterization of primary amino acid sequence of human complement control protein factor I from an analysis of cDNA clones [J]. Biochem J, 1987,242(3) :849-856.
  • 9Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 [J]. Hum Mol Genet, 2005, 14(5) : 703-712.
  • 10Geelen J, van den Dries K, Roos A, etal. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome [J]. Pediatr Nephrol,2007,22 (3): 371-375.

二级参考文献13

  • 1Richards A, Kathryn Liszewski M, Kavanagh D, et al. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome [J]. Mol Immunol,2007,44(3) : 111-122.
  • 2Noris M, Remuzzi G. Hemolytic uremic syndrome [J]. J Am Soc Nephrol,2005,16(4) : 1035-1050.
  • 3Loirat C, Noris M, Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome in children [J]. Pediatr Nephrol, 2008,23 ( 11 ) : 1957-1972.
  • 4Fremeaux-Bacchi V, Moulton EA, Kavanagh D, et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome [J]. J Am Soc Nephrol,2006,17(7) :2017-2025.
  • 5Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human complement regulator,membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome [J]. Proc Natl Acad Sci USA,2003,100 (22) : 12966-12971.
  • 6Esparza-Gordillo J, Goicoechea de Jorge E, Buil A, et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 [J]. Hum Mol Genet,2005,14(5):703-712.
  • 7Caprioli J, Nolis M, Brioschi S, et al . Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome [J ]. Blood,2006, 108(4) : 1267-1279.
  • 8Thompson R, Winterborn M. Hypocomplementaemia due to a genetic deficiency of beta-1H globulin [J]. Clin Exp Immunol, 1981,46(1 ) : 110-119.
  • 9Warwicker P, Goodship TH, Donne RL, et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome [J] . Kidney Int, 1998,53(4) :836-844.
  • 10Atkinson JP, Liszewski MK, Richards A, et al. Hemolytic uremic syndrome: an example of insufficient complement regulation on self-tissue [J]. Ann N Y Acad Sci, 2005,1056: 144-152.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部